Insider Trading activities of Genomic Health Inc (GHDX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005. The reporting company's ticker symbol is GHDX. The reporting company's CIK number is 1131324.
The total value of stock buying since 2005 is $432,617,427.
The total value of stock sales since 2005 is $579,134,437.
The total value of stock option exercises since 2005 is $58,528,110.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 37,643,330 $0 0 $0 0 $0
2019-10 0 $0 50,243 $3,474,351 40,243 $1,148,140
2019-09 0 $0 82,612 $5,979,926 47,612 $1,354,033
2019-08 0 $0 740,035 $54,348,279 607,854 $17,843,618
2019-07 0 $0 66,306 $3,796,472 16,306 $414,942
2019-06 0 $0 99,295 $5,156,320 95,050 $2,881,256
2019-05 0 $0 43,668 $2,527,423 15,924 $369,433
2019-04 0 $0 1,127,065 $75,997,568 18,000 $394,560
2019-03 0 $0 953,706 $71,500,150 56,200 $1,469,119
2019-02 0 $0 252,034 $19,873,329 209,862 $4,141,970
2019-01 0 $0 840,431 $60,186,905 70,222 $1,926,131
2018-12 0 $0 584,964 $44,114,935 44,250 $896,991
2018-11 0 $0 1,758,955 $140,039,966 110,576 $2,742,520
2018-10 0 $0 112,000 $7,300,311 112,000 $2,815,364
2018-09 0 $0 20,250 $1,270,622 20,250 $560,845
2018-08 0 $0 91,905 $4,958,171 40,279 $781,054
2018-07 0 $0 15,500 $803,442 15,500 $267,114
2018-06 0 $0 108,914 $5,032,005 96,268 $2,313,613
2018-05 0 $0 16,997 $631,277 15,500 $267,114
2018-04 0 $0 15,000 $497,880 15,000 $257,700
2018-03 0 $0 10,000 $325,635 59,500 $1,088,299
2018-02 0 $0 23,316 $770,230 15,000 $258,449
2018-01 0 $0 18,004 $633,341 17,169 $296,037
2017-12 0 $0 51,334 $1,675,587 51,000 $980,958
2017-11 0 $0 11,996 $385,161 9,831 $170,369
2017-10 0 $0 5,000 $159,635 5,000 $86,649
2017-09 0 $0 10,000 $314,280 10,000 $173,298
2017-08 0 $0 18,000 $548,683 16,500 $324,813
2017-07 0 $0 13,174 $433,618 10,000 $173,298
2017-06 0 $0 15,000 $486,290 15,000 $289,848
2017-05 0 $0 43,000 $1,295,783 92,500 $1,666,500
2017-04 0 $0 10,000 $313,830 10,000 $218,150
2017-03 0 $0 18,782 $585,007 15,710 $366,199
2017-02 0 $0 12,495 $366,902 10,000 $233,100
2017-01 0 $0 10,000 $282,470 10,000 $233,100
2016-12 0 $0 30,000 $903,530 30,000 $699,300
2016-11 0 $0 22,381 $685,555 18,913 $374,038
2016-10 0 $0 16,290 $494,567 13,290 $269,369
2016-09 0 $0 9,000 $243,791 9,000 $170,010
2016-08 100,000 $2,701,600 13,000 $366,813 10,000 $188,900
2016-07 0 $0 10,000 $270,335 10,000 $188,900
2016-06 0 $0 11,997 $321,506 11,997 $226,623
2016-05 0 $0 23,324 $623,210 66,500 $852,265
2016-01 0 $0 12,250 $384,125 12,250 $221,202
2015-12 0 $0 15,200 $448,902 15,200 $250,420
2015-11 0 $0 4,000 $104,128 4,000 $75,560
2015-09 0 $0 9,664 $244,990 9,664 $90,744
2015-07 0 $0 4,000 $110,112 4,000 $37,560
2015-06 0 $0 4,000 $104,964 4,000 $37,560
2015-05 0 $0 4,000 $110,240 4,000 $37,560
2015-04 0 $0 7,000 $215,588 7,000 $94,230
2015-03 0 $0 7,000 $224,274 7,000 $94,230
2015-02 0 $0 8,000 $246,964 8,000 $104,960
2015-01 0 $0 3,000 $100,386 3,000 $56,670
2014-12 0 $0 7,336 $240,233 7,336 $97,385
2014-11 0 $0 11,300 $399,872 11,300 $150,977
2014-10 0 $0 7,000 $207,421 7,000 $94,230
2014-09 0 $0 7,700 $230,872 7,700 $71,254
2014-08 0 $0 16,348 $443,430 16,348 $66,612
2014-07 0 $0 12,300 $330,956 12,300 $54,954
2014-06 0 $0 16,337 $439,288 16,337 $127,200
2014-05 0 $0 7,000 $180,691 7,000 $100,310
2014-04 0 $0 10,000 $266,654 10,000 $28,800
2014-03 0 $0 10,000 $281,781 10,000 $28,800
2014-02 0 $0 11,312 $309,215 10,000 $28,800
2014-01 0 $0 12,500 $380,099 12,500 $52,275
2013-12 0 $0 20,500 $625,409 20,500 $126,290
2013-11 0 $0 10,868 $362,423 10,868 $102,753
2013-10 0 $0 10,000 $298,225 5,000 $18,662
2013-09 0 $0 15,000 $498,838 10,000 $90,275
2013-08 0 $0 14,000 $464,197 9,000 $79,245
2013-07 0 $0 16,500 $568,261 11,500 $87,045
2013-06 509,773 $18,501,177 12,500 $438,906 7,500 $83,375
2013-05 563,790 $20,185,361 20,087 $721,927 15,087 $135,626
2013-04 0 $0 5,000 $144,482 5,000 $10,525
2013-03 0 $0 2,500 $71,435 2,500 $3,325
2013-02 217,445 $6,119,759 46,466 $1,318,016 43,750 $781,960
2013-01 0 $0 7,125 $200,739 7,125 $30,627
2012-12 0 $0 15,500 $431,107 5,500 $31,495
2012-11 1,156,239 $31,525,505 48,116 $1,306,607 7,500 $34,149
2012-10 0 $0 21,750 $736,466 11,750 $174,382
2012-09 0 $0 12,500 $414,765 2,500 $3,325
2012-08 0 $0 34,000 $1,180,157 32,250 $372,570
2012-07 0 $0 46,600 $1,652,117 6,600 $54,930
2012-06 0 $0 42,500 $1,429,860 2,500 $3,325
2012-05 854,973 $26,965,075 74,794 $2,398,312 7,500 $119,875
2012-04 0 $0 35,500 $1,013,613 4,500 $5,979
2012-03 428,145 $12,789,188 63,500 $1,939,635 2,500 $3,325
2012-02 1,846,592 $52,044,225 38,255 $1,037,135 2,500 $3,325
2012-01 0 $0 40,500 $1,103,159 4,500 $5,979
2011-12 304,071 $8,528,204 27,500 $753,560 2,500 $3,325
2011-11 1,415,609 $37,478,369 27,500 $741,665 7,500 $50,275
2011-10 0 $0 32,000 $721,125 12,000 $56,254
2011-09 0 $0 27,500 $569,710 7,500 $50,275
2011-08 0 $0 27,500 $666,981 7,500 $50,275
2011-07 0 $0 32,000 $876,856 12,000 $56,254
2011-06 491,170 $12,969,827 28,500 $740,781 7,500 $50,275
2011-05 116,208 $3,167,096 28,500 $752,196 7,500 $50,275
2011-04 0 $0 41,000 $1,061,996 15,000 $124,724
2011-03 1,019,260 $25,953,993 70,820 $1,789,399 13,000 $122,070
2011-02 85,476 $2,144,763 34,000 $762,991 18,000 $183,495
2011-01 0 $0 34,276 $741,307 14,276 $33,364
2010-12 0 $0 30,500 $687,520 10,500 $26,365
2010-11 0 $0 30,500 $550,440 60,500 $542,865
2010-10 0 $0 20,000 $279,000 0 $0
2010-09 51,342 $745,705 30,234 $451,764 10,234 $25,598
2010-08 864,973 $12,611,379 35,129 $520,597 10,500 $26,365
2010-07 0 $0 24,629 $316,583 0 $0
2010-06 0 $0 24,629 $347,952 0 $0
2010-05 0 $0 35,129 $550,000 10,500 $26,365
2010-04 0 $0 29,629 $500,051 5,000 $6,650
2010-03 0 $0 153,829 $2,990,247 2,500 $3,325
2010-02 500,088 $8,496,802 27,129 $467,639 2,500 $3,325
2010-01 0 $0 9,629 $167,114 5,000 $6,650
2009-12 0 $0 28,629 $580,159 0 $0
2009-11 0 $0 37,294 $730,015 665 $884
2009-10 0 $0 26,629 $551,250 0 $0
2009-09 0 $0 26,629 $550,538 0 $0
2009-08 360,972 $7,116,249 31,629 $624,684 5,000 $6,650
2009-07 0 $0 4,629 $74,114 0 $0
2009-06 0 $0 10,629 $191,497 0 $0
2009-05 321,783 $6,216,101 26,629 $520,450 0 $0
2009-04 0 $0 16,629 $425,350 0 $0
2009-03 0 $0 16,629 $321,343 0 $0
2009-02 0 $0 21,629 $455,022 5,000 $6,650
2009-01 0 $0 4,629 $89,858 0 $0
2008-12 0 $0 16,729 $311,955 69,348 $219,833
2008-11 0 $0 26,629 $535,565 10,000 $13,300
2008-10 0 $0 25,887 $553,977 0 $0
2008-09 0 $0 30,887 $691,589 0 $0
2008-08 0 $0 55,927 $1,330,867 5,000 $6,650
2008-07 0 $0 16,629 $341,136 0 $0
2008-06 493,611 $9,796,688 16,729 $324,292 0 $0
2008-05 0 $0 16,629 $314,159 0 $0
2008-04 0 $0 12,000 $206,658 0 $0
2008-03 0 $0 16,629 $320,821 0 $0
2008-02 0 $0 30,629 $686,732 10,201 $9,645
2008-01 0 $0 16,629 $411,393 0 $0
2007-12 0 $0 4,629 $106,906 0 $0
2007-11 0 $0 11,284 $253,849 0 $0
2007-10 0 $0 16,629 $333,777 0 $0
2007-09 0 $0 40,629 $799,617 0 $0
2007-08 5,350 $100,387 16,629 $328,861 0 $0
2007-07 0 $0 16,629 $342,235 0 $0
2007-06 0 $0 16,629 $311,131 0 $0
2007-05 4,000,143 $64,065,260 16,629 $274,912 0 $0
2007-04 0 $0 16,629 $286,649 43,345 $27,480
2007-03 628,786 $11,484,376 16,629 $304,353 0 $0
2007-02 811,781 $14,845,020 16,629 $305,182 0 $0
2006-12 953,338 $19,285,985 0 $0 0 $0
2006-09 1,195,954 $16,779,333 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Genomic Health Inc insiders (GHDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-08 Exact Sciences Corp (Other) Buy 37,643,330 .00 0
2019-10-17 Leber Laura (Chief Communication Officer) Sale 13,183 70.94 935,228
2019-10-17 Leber Laura (Chief Communication Officer) Option Ex 13,183 22.98 302,945
2019-10-08 Vaughn James J (Chief Commercial Officer) Sale 4,500 67.75 304,875
2019-10-08 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 33.21 149,445
2019-10-08 Popovits Kimberly J (President and CEO) Sale 10,000 67.74 677,360
2019-10-07 Cole G Bradley (CFO) Sale 22,560 69.01 1,556,888
2019-10-07 Cole G Bradley (CFO) Option Ex 22,560 30.84 695,750
2019-09-17 Shak Steven (Chief Scientific Officer) Sale 25,000 71.47 1,786,700
2019-09-10 Cole G Bradley (CFO) Sale 18,112 71.96 1,303,411
2019-09-10 Cole G Bradley (CFO) Option Ex 18,112 28.05 508,041
2019-09-09 Vaughn James J (Chief Commercial Officer) Sale 4,500 73.15 329,170
2019-09-09 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 32.16 144,742
2019-09-09 Cole G Bradley (CFO) Sale 25,000 73.15 1,828,825
2019-09-09 Cole G Bradley (CFO) Option Ex 25,000 28.05 701,250
2019-09-09 Popovits Kimberly J (President and CEO) Sale 10,000 73.18 731,820
2019-08-19 Pla Frederic (COO) Sale 1,251 75.00 93,825
2019-08-19 Pla Frederic (COO) Option Ex 1,251 27.48 34,377
2019-08-15 Radford Jason W. (Chief Legal Officer) Sale 2,181 74.45 162,368
2019-08-13 Popovits Kimberly J (President and CEO) Sale 50,000 74.20 3,710,000
2019-08-13 Popovits Kimberly J (President and CEO) Option Ex 30,000 29.34 880,200
2019-08-12 Cole G Bradley (CFO) Sale 240,000 73.53 17,646,240
2019-08-12 Cole G Bradley (CFO) Option Ex 240,000 29.34 7,041,600
2019-08-12 Popovits Kimberly J (President and CEO) Sale 50,000 73.53 3,676,400
2019-08-12 Popovits Kimberly J (President and CEO) Option Ex 50,000 29.34 1,467,000
2019-08-09 Popovits Kimberly J (President and CEO) Sale 25,000 74.00 1,850,025
2019-08-09 Popovits Kimberly J (President and CEO) Option Ex 25,000 29.34 733,500
2019-08-08 Vaughn James J (Chief Commercial Officer) Sale 4,500 73.67 331,515
2019-08-08 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 31.82 143,176
2019-08-08 Popovits Kimberly J (President and CEO) Sale 25,000 73.93 1,848,200
2019-08-08 Popovits Kimberly J (President and CEO) Option Ex 25,000 29.34 733,500
2019-08-06 Shak Steven (Chief Scientific Officer) Sale 25,000 72.50 1,812,474
2019-08-05 Mceachron Kim (Chief People Officer) Sale 12,103 71.53 865,727
2019-08-05 Mceachron Kim (Chief People Officer) Option Ex 12,103 29.37 355,465
2019-08-05 Shak Steven (Chief Scientific Officer) Sale 25,000 71.54 1,788,425
2019-08-02 Shak Steven (Chief Scientific Officer) Sale 25,000 72.43 1,810,850
2019-08-01 Shak Steven (Chief Scientific Officer) Sale 25,000 72.97 1,824,350
2019-07-09 Cole G Bradley (CFO) Sale 6,471 56.78 367,416
2019-07-09 Cole G Bradley (CFO) Option Ex 6,471 17.18 111,171
2019-07-09 Shak Steven (Chief Scientific Officer) Sale 25,000 56.66 1,416,625
2019-07-08 Vaughn James J (Chief Commercial Officer) Sale 4,500 57.37 258,178
2019-07-08 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 31.12 140,040
2019-07-08 Shak Steven (Chief Scientific Officer) Sale 25,000 57.36 1,434,100
2019-07-05 Mceachron Kim (Chief People Officer) Sale 5,335 60.01 320,153
2019-07-05 Mceachron Kim (Chief People Officer) Option Ex 5,335 30.69 163,731
2019-06-14 Shak Steven (Chief Scientific Officer) Sale 10,550 51.91 547,639
2019-06-14 Shak Steven (Chief Scientific Officer) Option Ex 10,550 31.12 328,316
2019-06-13 Shak Steven (Chief Scientific Officer) Sale 25,000 52.18 1,304,450
2019-06-13 Shak Steven (Chief Scientific Officer) Option Ex 25,000 31.12 778,000
2019-06-12 Shak Steven (Chief Scientific Officer) Sale 25,000 51.34 1,283,475
2019-06-12 Shak Steven (Chief Scientific Officer) Option Ex 25,000 30.98 774,500
2019-06-11 Cole G Bradley (CFO) Sale 5,000 51.82 259,090
2019-06-11 Cole G Bradley (CFO) Option Ex 5,000 17.18 85,900
2019-06-11 Shak Steven (Chief Scientific Officer) Sale 25,000 51.80 1,295,025
2019-06-11 Shak Steven (Chief Scientific Officer) Option Ex 25,000 30.98 774,500
2019-06-06 Vaughn James J (Chief Commercial Officer) Sale 8,745 53.36 466,641
2019-06-06 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 31.12 140,040
2019-05-14 Cole G Bradley (CFO) Sale 11,424 56.97 650,848
2019-05-14 Cole G Bradley (CFO) Option Ex 11,424 20.08 229,393
2019-05-08 Vaughn James J (Chief Commercial Officer) Sale 7,244 57.95 419,775
2019-05-08 Vaughn James J (Chief Commercial Officer) Option Ex 4,500 31.12 140,040
2019-05-08 Shak Steven (Chief Scientific Officer) Sale 25,000 58.27 1,456,800
2019-04-12 Baker Bros. Investments Ii, L.p. (Director) Sale 298,669 65.60 19,668,646
2019-04-11 Baker Bros. Investments Ii, L.p. (Director) Sale 202,281 67.01 13,555,658
2019-04-10 Baker Bros. Investments Ii, L.p. (Director) Sale 137,688 68.91 9,464,849
2019-04-09 Baker Bros. Investments Ii, L.p. (Director) Sale 21,063 67.77 1,427,502
2019-04-09 Cole G Bradley (CFO) Sale 15,000 67.83 1,017,479
2019-04-09 Cole G Bradley (CFO) Option Ex 15,000 20.08 301,200
2019-04-08 Vaughn James J (Chief Commercial Officer) Sale 3,000 67.58 202,745
2019-04-08 Vaughn James J (Chief Commercial Officer) Option Ex 3,000 31.12 93,360
2019-04-08 Baker Bros. Investments Ii, L.p. (Director) Sale 22,648 67.90 1,537,731
2019-04-08 Popovits Kimberly J (President and CEO) Sale 10,000 67.53 675,260
2019-04-05 Baker Bros. Investments Ii, L.p. (Director) Sale 77,648 68.67 5,332,243
2019-04-04 Baker Bros. Investments Ii, L.p. (Director) Sale 81,053 66.64 5,401,371
2019-04-03 Baker Bros. Investments Ii, L.p. (Director) Sale 97,269 68.90 6,701,736
2019-04-01 Shak Steven (Chief Scientific Officer) Sale 25,000 68.97 1,724,299
2019-03-29 Shak Steven (Chief Scientific Officer) Sale 25,000 69.79 1,744,700
2019-03-28 Shak Steven (Chief Scientific Officer) Sale 25,000 68.95 1,723,750
2019-03-21 Baker Bros. Investments Ii, L.p. (Director) Sale 56,651 74.71 4,232,169
2019-03-19 Pla Frederic (COO) Sale 4,700 75.00 352,500
2019-03-19 Pla Frederic (COO) Option Ex 4,700 28.82 135,454
2019-03-19 Baker Bros. Investments Ii, L.p. (Director) Sale 155,226 74.49 11,570,242
2019-03-18 Pla Frederic (COO) Sale 1,000 75.12 75,122
2019-03-18 Pla Frederic (COO) Option Ex 1,000 27.48 27,480
2019-03-18 Baker Bros. Investments Ii, L.p. (Director) Sale 109,533 74.19 8,125,924
2019-03-15 Baker Bros. Investments Ii, L.p. (Director) Sale 55,347 75.25 4,164,806
2019-03-14 Baker Bros. Investments Ii, L.p. (Director) Sale 65,094 76.27 4,964,459
2019-03-13 Baker Bros. Investments Ii, L.p. (Director) Sale 80,253 75.79 6,082,294
2019-03-12 Baker Bros. Investments Ii, L.p. (Director) Sale 74,180 75.63 5,610,233
2019-03-12 Cole G Bradley (CFO) Sale 15,000 75.40 1,130,940
2019-03-12 Cole G Bradley (CFO) Option Ex 15,000 20.08 301,200
2019-03-11 Baker Bros. Investments Ii, L.p. (Director) Sale 49,035 74.56 3,655,902
2019-03-08 Baker Bros. Investments Ii, L.p. (Director) Sale 22,700 73.55 1,669,516
2019-03-08 Popovits Kimberly J (President and CEO) Sale 10,000 73.44 734,449
2019-03-07 Vaughn James J (Chief Commercial Officer) Sale 3,000 73.92 221,751
2019-03-07 Vaughn James J (Chief Commercial Officer) Option Ex 3,000 31.12 93,360
2019-03-07 Baker Bros. Investments Ii, L.p. (Director) Sale 2,000 73.72 147,444
2019-03-05 Baker Bros. Investments Ii, L.p. (Director) Sale 10,300 77.04 793,501
2019-03-04 Baker Bros. Investments Ii, L.p. (Director) Sale 27,811 76.49 2,127,263
2019-03-04 Shak Steven (Chief Scientific Officer) Sale 7,500 76.23 571,740
2019-03-04 Shak Steven (Chief Scientific Officer) Option Ex 7,500 28.05 210,375
2019-03-01 Baker Bros. Investments Ii, L.p. (Director) Sale 79,276 77.39 6,135,486
2019-03-01 Shak Steven (Chief Scientific Officer) Sale 25,000 77.66 1,941,375
2019-03-01 Shak Steven (Chief Scientific Officer) Option Ex 25,000 28.05 701,250
2019-02-28 Shak Steven (Chief Scientific Officer) Sale 25,000 76.42 1,910,425
2019-02-28 Shak Steven (Chief Scientific Officer) Option Ex 25,000 22.61 565,375
2019-02-27 Baker Bros. Advisors (gp) Llc (Director) Sale 39,109 76.43 2,989,139
2019-02-27 Shak Steven (Chief Scientific Officer) Sale 25,000 76.91 1,922,700
2019-02-27 Shak Steven (Chief Scientific Officer) Option Ex 25,000 17.18 429,500
2019-02-26 Baker Bros. Advisors (gp) Llc (Director) Sale 8,650 77.97 674,440
2019-02-26 Baker Bros. Advisors (gp) Llc (Director) Option Ex 16,500 17.59 290,235
2019-02-21 Leber Laura (Chief Communication Officer) Sale 5,634 83.14 468,433
2019-02-21 Leber Laura (Chief Communication Officer) Option Ex 1,817 22.98 41,754
2019-02-21 Pla Frederic (COO) Sale 783 86.51 67,736
2019-02-20 Leber Laura (Chief Communication Officer) Sale 18,750 83.12 1,558,462
2019-02-20 Leber Laura (Chief Communication Officer) Option Ex 18,750 17.18 322,125
2019-02-19 Vaughn James J (Chief Commercial Officer) Option Ex 1,195 29.06 34,726
2019-02-19 Radford Jason W. (Chief Legal Officer) Sale 3,508 83.38 292,507
2019-02-19 Pla Frederic (COO) Sale 9,700 83.24 807,428
2019-02-19 Pla Frederic (COO) Option Ex 5,700 28.82 164,274
2019-02-14 Popovits Kimberly J (President and CEO) Sale 47,900 81.88 3,922,052
2019-02-14 Popovits Kimberly J (President and CEO) Option Ex 47,900 17.18 822,922
2019-02-12 Cole G Bradley (CFO) Sale 15,000 80.91 1,213,575
2019-02-12 Cole G Bradley (CFO) Option Ex 15,000 20.08 301,200
2019-02-07 Vaughn James J (Chief Commercial Officer) Sale 3,000 77.56 232,683
2019-02-07 Vaughn James J (Chief Commercial Officer) Option Ex 3,000 31.12 93,360
2019-02-04 Shak Steven (Chief Scientific Officer) Sale 25,000 76.61 1,915,149
2019-02-04 Shak Steven (Chief Scientific Officer) Option Ex 25,000 20.08 501,999
2019-02-01 Shak Steven (Chief Scientific Officer) Sale 25,000 75.94 1,898,600
2019-02-01 Shak Steven (Chief Scientific Officer) Option Ex 25,000 22.98 574,500
2019-01-31 Shak Steven (Chief Scientific Officer) Sale 25,000 74.78 1,869,575
2019-01-31 Shak Steven (Chief Scientific Officer) Option Ex 25,000 29.34 733,500
2019-01-30 Shak Steven (Chief Scientific Officer) Sale 25,000 73.49 1,837,249
2019-01-30 Shak Steven (Chief Scientific Officer) Option Ex 25,000 29.34 733,500
2019-01-28 Baker Bros. Advisors (gp) Llc (Director) Sale 46,477 70.95 3,297,636
2019-01-25 Baker Bros. Advisors (gp) Llc (Director) Sale 91,916 72.20 6,636,610
2019-01-24 Baker Bros. Advisors (gp) Llc (Director) Sale 79,403 72.02 5,718,604
2019-01-23 Baker Bros. Advisors (gp) Llc (Director) Sale 37,512 71.99 2,700,338
2019-01-22 Radford Jason W. (Chief Legal Officer) Sale 2,963 71.46 211,738
2019-01-22 Baker Bros. Investments Ii, L.p. (Director) Sale 64,406 71.31 4,580,672
2019-01-18 Baker Bros. Investments Ii, L.p. (Director) Sale 177,142 72.51 12,844,212
2019-01-17 Vaughn James J (Chief Commercial Officer) Option Ex 2,222 29.06 64,571
2019-01-17 Baker Bros. Investments Ii, L.p. (Director) Sale 181,747 70.79 12,866,051
2019-01-14 Baker Bros. Investments Ii, L.p. (Director) Sale 600 70.07 42,043
2019-01-11 Baker Bros. Investments Ii, L.p. (Director) Sale 28,474 70.22 1,999,529
2019-01-10 Baker Bros. Investments Ii, L.p. (Director) Sale 10,185 70.28 715,781
2019-01-08 Vaughn James J (Chief Commercial Officer) Sale 3,000 66.93 200,796
2019-01-08 Vaughn James J (Chief Commercial Officer) Option Ex 3,000 31.12 93,360
2019-01-08 Cole G Bradley (CFO) Sale 15,000 66.80 1,002,045
2019-01-08 Cole G Bradley (CFO) Option Ex 15,000 20.08 301,200

Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month